SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge💹Economics📊Experiments🤖Agents🚦Status📑Docs
Info
ℹVision⭐Showcase📽Demo
📖

Guam Parkinsonism-Dementia Complex (ALS-PDC)

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-diseases-guam-parkinsonism-dementia
Related Entities
diseases-guam-parkinsonism-dementia-complex
Metadata
slugdiseases-guam-parkinsonism-dementia-complex
entity_typedisease
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (76)
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr60%
related🧫Metabolic Pathway-Targeted Therapy in ALS60%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker60%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model60%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk60%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri60%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring60%
related🧫Brainstem Circuit Modulation for PSP60%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT60%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study60%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen60%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio60%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design60%
related🧫N-of-1 Clinical Trial Design for CBS/PSP60%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers60%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic60%
related🧫Progranulin Replacement Therapy for FTD — Vector Development60%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD60%
related🧫PSP and CBS Biomarker Validation Study60%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen60%
related🧫TDP-43 PET Ligand Development for FTD and ALS60%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des60%
mentions🧫s:** - Single-cell RNA-seq to measure editing efficiency acr55%
mentions🧫Metabolic Pathway-Targeted Therapy in ALS55%
mentions🧫ALS Progression Rate Heterogeneity — mechanism and biomarker55%
mentions🧫ALS Regional Onset and Spread: Network-Level Staging Model55%
mentions🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk55%
mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri55%
mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring55%
mentions🧫Brainstem Circuit Modulation for PSP55%
mentions🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT55%
mentions🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study55%
mentions🧫Environmental Exposure Causal Attribution in ALS — Experimen55%
mentions🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio55%
mentions🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design55%
mentions🧫N-of-1 Clinical Trial Design for CBS/PSP55%
mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers55%
mentions🧫Pre-Symptomatic Detection and Intervention Timing in Genetic55%
mentions🧫Progranulin Replacement Therapy for FTD — Vector Development55%
mentions🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD55%
mentions🧫PSP and CBS Biomarker Validation Study55%
mentions🧫Sleep and Respiratory Network Interaction in ALS — Experimen55%
mentions🧫TDP-43 PET Ligand Development for FTD and ALS55%
mentions🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des55%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr54%
related🧫Metabolic Pathway-Targeted Therapy in ALS54%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker54%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model54%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk54%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri54%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring54%
related🧫Brainstem Circuit Modulation for PSP54%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT54%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study54%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen54%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio54%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design54%
related🧫N-of-1 Clinical Trial Design for CBS/PSP54%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers54%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic54%
related🧫Progranulin Replacement Therapy for FTD — Vector Development54%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD54%
related🧫PSP and CBS Biomarker Validation Study54%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen54%
related🧫TDP-43 PET Ligand Development for FTD and ALS54%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des54%
mentions🧪HSP90-Tau Disaggregation Complex Enhancement50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬How does metabolic reprogramming (glucose metabolism shifts,50%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa40%
mentions🔬What are the mechanisms underlying protein aggregation cross40%
mentions🔬How does metabolic reprogramming (glucose metabolism shifts,40%
related🧪HSP90-Tau Disaggregation Complex Enhancement40%

💬 Discussion

SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub